Home » Stocks » HRC

Hill-Rom Holdings, Inc. (HRC)

Stock Price: $111.22 USD 2.71 (2.50%)
Updated May 13, 2021 4:00 PM EDT - Market closed
Market Cap 7.21B
Revenue (ttm) 2.98B
Net Income (ttm) 282.20M
Shares Out 66.37M
EPS (ttm) 4.21
PE Ratio 26.41
Forward PE 20.49
Dividend $0.90
Dividend Yield 0.81%
Trading Day May 13
Last Price $111.22
Previous Close $108.51
Change ($) 2.71
Change (%) 2.50%
Day's Open 108.49
Day's Range 108.15 - 111.84
Day's Volume 415,234
52-Week Range 79.94 - 117.67

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Tech stocks like Apple, Facebook, Alphabet, and Amazon have all dropped again. But Q.ai's artificial intelligence systems have assessed each firm to find the best top buys.

Other stocks mentioned: CTAS, FDX, PII, VRT
2 days ago - Forbes

CHICAGO, May 10, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021. Barbara Bodem, Hillrom's SVP & Chi...

3 days ago - PRNewsWire

CHICAGO, May 4, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2021 third quarter dividend of $0.24 per share payable on June 30, 2021, to shareho...

1 week ago - PRNewsWire

Hill-Rom's (HRC) second-quarter revenues improved year over year on continued recovery across all three business segments as well as expanded demand for critical care products.

1 week ago - Zacks Investment Research

Hill-Rom (HRC) delivered earnings and revenue surprises of 20.98% and 4.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Hill-Rom (NYSE: HRC) reported Q2 Non-GAAP earnings rose 35% at $1.73 and exceeded the company's guidance range of $1.40 to $1.45 and surpassed analyst consensus of $1.43. GAAP earnings of $1.30 higher t...

1 week ago - Benzinga

Shares of Hill-Rom Holdings (NYSE:HRC) moved higher by 1.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 35.16% year over year to $1.73, whic...

1 week ago - Benzinga

CHICAGO, April 30, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal second quarter ended March 31, 2021, and raised its fiscal 2021 guidance. For the fiscal seco...

1 week ago - PRNewsWire

CHICAGO, April 28, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. John Groetelaars, Hi...

2 weeks ago - PRNewsWire

CHICAGO, April 21, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™...

3 weeks ago - PRNewsWire

CHICAGO, April 11, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intent to acquire Bardy Diagnostics, Inc. (BardyDx). On April 10, 2021, the Medicare Administrative Contractor (MAC),...

1 month ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: BLFS
1 month ago - Zacks Investment Research

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: CMD, LMAT, MASI, RMD
1 month ago - Zacks Investment Research

CHICAGO, April 5, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal second quarter 2021 earnings conference call and webcast on Friday, April 30, 2021, beginning at 7:30 a.m. (CT) / 8:30 a.m.

1 month ago - PRNewsWire

Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.

Other stocks mentioned: IVC, MCK, RMD, XENT
1 month ago - Zacks Investment Research

Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.

Other stocks mentioned: OMI, PKI, SRDX
1 month ago - Zacks Investment Research

Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: BDX, MCK, OMI, VIVO
1 month ago - Zacks Investment Research

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: ABT, CSII, HOLX, IDXX, LH, LMAT
1 month ago - Zacks Investment Research

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: BLFS
1 month ago - Zacks Investment Research

Investors continue to be optimistic about robust demand for Hill-Rom's (HRC) product as well as its solid first-quarter fiscal 2021 results.

1 month ago - Zacks Investment Research

CHICAGO, March 11, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a 9 percent increase in the company's quarterly dividend rate, from the previous rate of ...

2 months ago - PRNewsWire

CHICAGO, March 10, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021. John Groet...

2 months ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: BLFS
2 months ago - Zacks Investment Research

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

As bond yields pop and the rotation out of tech into recovery plays continues, Q.ai's Artificial Intelligence has brought you today's top buys.

Other stocks mentioned: AFL, CAG, ICUI, SJW
2 months ago - Forbes

CHICAGO, March 1, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021. On...

2 months ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other stocks mentioned: BLFS
2 months ago - Zacks Investment Research

Hill-Rom Holdings (HRC) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

2 months ago - Zacks Investment Research

Hill-Rom (HRC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago - Zacks Investment Research

Hill-Rom's (HRC) first-quarter fiscal 2021 revenue climbed 8.2% year over year to $741.1 million.

3 months ago - Zacks Investment Research

Hill-Rom (HRC) delivered earnings and revenue surprises of 45.71% and 13.21%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Hill-Rom Holdings (NYSE:HRC) rose 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 35.40% year over year to $1.53, which beat th...

3 months ago - Benzinga

CHICAGO, Feb. 5, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal first quarter ended December 31, 2020, and raised its fiscal 2021 guidance. For the fiscal firs...

3 months ago - PRNewsWire

CHICAGO, Jan. 31, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambul...

3 months ago - PRNewsWire

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

3 months ago - Zacks Investment Research

CHICAGO, Jan. 19, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leadin...

3 months ago - PRNewsWire

The S&P 500 saw its trailing 12-month real earnings per share increase by approximately 1% on average every year over the past five years. The index's share price ($3,768.25 as of Friday) has climbed 10...

Other stocks mentioned: LFUS, TCF
3 months ago - GuruFocus

Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.

Other stocks mentioned: BDX, CAH, MCK
4 months ago - Zacks Investment Research

CHICAGO, Jan. 7, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal first quarter 2021 earnings conference call and webcast on Friday, February 5, 2021, beginning at 7:30 a.m. (CT) / 8:30 a.m...

4 months ago - PRNewsWire

Hill-Rom (HRC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

4 months ago - Zacks Investment Research

Let's see if Hill-Rom Holdings (HRC) stock is a good choice for value-oriented investors right now from multiple angles.

5 months ago - Zacks Investment Research

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Within Front Line Care (FLC), Hill-Rom (HRC) registers growth in vital signs monitoring, blood pressure and thermometry as well as the completion of the U.S. stockpile order for noninvasive ventilators.

5 months ago - Zacks Investment Research

We believe that Hill-Rom Holdings stock (NYSE: HRC), best known for its hospital beds and patient mobility solutions, may be a good buying opportunity at the present time. HRC stock trades near $97 curr...

5 months ago - Forbes

Hill-Rom Holdings has enjoyed a strong 2H 2020, with sequential growth across quarters, and a mild recovery from Covid-related headwinds. Moderate stability in bed demand, strength in international mark...

5 months ago - Seeking Alpha

CHICAGO, Nov. 17, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Tuesday, December 1, 2020. John Groetelaar...

5 months ago - PRNewsWire

In Q3, Hill-Rom's (HRC) bed orders and backlog in the United States accelerates with sequential recovery in Patient Support Systems arm.

6 months ago - Zacks Investment Research

Hill-Rom Holdings, Inc. (HRC) CEO John Groetelaars on Q4 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Hill-Rom (HRC) delivered earnings and revenue surprises of 8.33% and 1.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

CHICAGO, Nov. 6, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full year ended September 30, 2020, and provided financial guidance for fisc...

6 months ago - PRNewsWire

About HRC

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1969
CEO
John Groetelaars
Employees
10,000
Stock Exchange
NYSE
Ticker Symbol
HRC
Full Company Profile

Financial Performance

In 2020, HRC's revenue was $2.88 billion, a decrease of -0.90% compared to the previous year's $2.91 billion. Earnings were $223.00 million, an increase of 46.52%.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for HRC stock is "Buy." The 12-month stock price forecast is 128.29, which is an increase of 15.35% from the latest price.

Price Target
$128.29
(15.35% upside)
Analyst Consensus: Buy